Robuta

https://pubmed.ncbi.nlm.nih.gov/39164653/ Application of artificial intelligence in chronic myeloid leukemia (CML) disease prediction and... AI offers groundbreaking insights and tools for enhancing prediction, prognosis, and personalized treatment in chronic myeloid leukemia. Integrated AI systems... chronic myeloid leukemiaartificial intelligence https://www.cmleukemia.com/ Chronic Myeloid Leukemia - CMLeukemia Chronic Myeloid Leukemia CML chronic myeloid leukemia https://eprints.ncl.ac.uk/232047 Chronic Myeloid Leukemia: Reminiscences And Dreams - ePrints - Newcastle University chronic myeloid leukemiareminiscencesdreamseprintsnewcastle https://www.mdpi.com/2077-0383/10/24/5805 Shedding Light on Targeting Chronic Myeloid Leukemia Stem Cells Chronic myeloid leukemia stem cells (CML LSCs) are a rare and quiescent population that are resistant to tyrosine kinase inhibitors (TKI). When TKI therapy is... chronic myeloid leukemiashedding lighttargetingstemcells https://www.speakupcml.com/ Chronic Myeloid Leukemia | Speak Up CML Learn more about Chronic Myeloid Leukemia (CML). Find information and resources for talking with your doctor about any burdens you may be facing. chronic myeloid leukemiaspeak upcml https://medlineplus.gov/genetics/condition/chronic-myeloid-leukemia/ Chronic myeloid leukemia: MedlinePlus Genetics Chronic myeloid leukemia is a slow-growing cancer of the blood-forming tissue (bone marrow). Explore symptoms, inheritance, genetics of this condition. chronic myeloid leukemiamedlineplusgenetics https://portal.fis.tum.de/en/publications/secondary-malignancies-in-chronic-myeloid-leukemia-patients-after-2/ Secondary malignancies in chronic myeloid leukemia patients after imatinib-based treatment:... chronic myeloid leukemiasecondary malignancies https://pubmed.ncbi.nlm.nih.gov/23127201/ Monitoring and switching patterns of patients with chronic myeloid leukemia treated with imatinib... Based on the guidelines, the rates of treatment monitoring and switching upon failure were low, demonstrating the need for improvement in CML care in community... chronic myeloid leukemia https://researchportal.helsinki.fi/fi/publications/novel-prognostic-factors-in-chronic-myeloid-leukemia/ Novel prognostic factors in chronic myeloid leukemia - Helsingin yliopisto chronic myeloid leukemiaprognostic factorsnovelhelsinginyliopisto https://profiles.wustl.edu/en/publications/specific-killing-of-phsupsup-chronic-myeloid-leukemia-cells-by-a-/ Specific Killing of Ph+ Chronic Myeloid Leukemia Cells by a Lentiviral Vector-Delivered... chronic myeloid leukemia https://www.pfizer.com/news/articles/living_with_chronic_myeloid_leukemia_cml Living with Chronic Myeloid Leukemia (CML) | Pfizer Chronic myeloid (or myelogenous) leukemia (CML) is one of four main types of leukemia that can affect adults. These 4 types of leukemia are classified as... chronic myeloid leukemialiving withcmlpfizer https://pubmed.ncbi.nlm.nih.gov/29992292/ Chronic Myeloid Leukemia Following Treatment for Primary Neoplasms or Other Medical Conditions Therapy-related CML has a clinical presentation, pathologic features, and cytogenetic profile akin to de novo CML. Absence of additional significant... chronic myeloid leukemiatreatment for https://www.frontiersin.org/journals/pharmacology/articles/10.3389/fphar.2021.674748/full Frontiers | Arterial Hypertension and Tyrosine Kinase Inhibitors in Chronic Myeloid Leukemia: A... Background: Off-target effects in chronic myeloid leukemia (CML) patients treated with Tyrosine kinase inhibitors (TKI) are associated with cardiovascular t... tyrosine kinase inhibitorschronic myeloid leukemiaarterial hypertension https://pubmed.ncbi.nlm.nih.gov/32127639/?tool=bestpractice.com European LeukemiaNet 2020 recommendations for treating chronic myeloid leukemia The therapeutic landscape of chronic myeloid leukemia (CML) has profoundly changed over the past 7 years. Most patients with chronic phase (CP) now have a... europeanrecommendationstreatingchronicmyeloid https://www.wikidata.org/wiki/Q37692798 Dasatinib or high-dose imatinib for chronic-phase chronic myeloid leukemia resistant to imatinib at... scientific article published on September 2009 https://adisinsight.springer.com/trials/700303406?error=cookies_not_supported&code=48b89333-e97f-4875-b8e9-bed16572827a Effect of food consumption on pharmacokinetics of nilotinib in Chronic Myeloid Leukemia -... The purpose of this study is to evaluate the effects of food on pharmacokinetics of nilotinib in chronic myeloid leukemia patients. food consumptioneffect https://pubmed.ncbi.nlm.nih.gov/34052176/ Efficacy and Safety of Imatinib Treatment in Elderly Patients With Chronic Myeloid Leukemia:... Upfront imatinib was generally well tolerated among elderly Turkish patients with CML with non-inferior responses and long-term outcomes when compared with... efficacy and safety https://pubmed.ncbi.nlm.nih.gov/23275297/ ADAR1 promotes malignant progenitor reprogramming in chronic myeloid leukemia The molecular etiology of human progenitor reprogramming into self-renewing leukemia stem cells (LSC) has remained elusive. Although DNA sequencing has... promotesmalignantprogenitorreprogrammingchronic https://pubmed.ncbi.nlm.nih.gov/28743166/ Second tyrosine kinase inhibitor discontinuation attempt in patients with chronic myeloid leukemia This study is the first to demonstrate that a second TKI discontinuation attempt is safe and that a first failed attempt at discontinuing TKI does not preclude... tyrosine kinase https://pubmed.ncbi.nlm.nih.gov/36258734/ OCT-1 Expression in Patients with Chronic Myeloid Leukemia: A Comparative Analysis with Respect to... The introduction of tyrosine kinase inhibitors (TKI) has resulted in a significant improvement in the treatment of CML patients. However, some CML patients are... https://portal.research.lu.se/sv/publications/role-of-znf224-in-c-myc-repression-and-imatinib-responsiveness-in/fingerprints/ Role of ZNF224 in c-Myc repression and imatinib responsiveness in chronic myeloid leukemia -... https://pubmed.ncbi.nlm.nih.gov/32127639/ European LeukemiaNet 2020 recommendations for treating chronic myeloid leukemia The therapeutic landscape of chronic myeloid leukemia (CML) has profoundly changed over the past 7 years. Most patients with chronic phase (CP) now have a... europeanrecommendationstreatingchronicmyeloid https://pubmed.ncbi.nlm.nih.gov/34055641/ Clinical Relevance of ABCB1, ABCG2, and ABCC2 Gene Polymorphisms in Chronic Myeloid Leukemia... Tyrosine kinase inhibitors (TKIs) have radically changed the outcome of chronic myeloid leukemia (CML) patients in the last 20 years. Moreover, the advent of... https://hsbiblio.uni-tuebingen.de/xmlui/handle/10900/51597 Rac2-MRC-cIII-generated ROS cause genomic instability in chronic myeloid leukemia stem cells and... https://www.sciencedaily.com/releases/2010/12/101206093713.htm Phase I trial indicates ponatinib may thwart most resistant chronic myeloid leukemia | ScienceDaily A new drug appears to help chronic myeloid leukemia patients who are out of treatment options after first- and second-line drugs have failed them or because... https://www.wikidata.org/wiki/Q28304079 AML1 and the 8;21 and 3;21 translocations in acute and chronic myeloid leukemia - Wikidata https://www.frontiersin.org/journals/medicine/articles/10.3389/fmed.2025.1515002/full Frontiers | Molecular response of a patient with e19a2-positive chronic myeloid leukemia to... ObjectiveChronic myeloid leukemia (CML) is a malignancy driven by the BCR::ABL1fusion gene, with the e19a2 transcript being a rare variant, accounting for 0.... https://pmc.ncbi.nlm.nih.gov/articles/PMC3010822/ Principal long-term adverse effects of imatinib in patients with chronic myeloid leukemia in... Imatinib mesylate (IM), an original Abl tyrosine kinase inhibitor, entered the clinics in 1998 for the treatment of patients with chronic myeloid leukemia... https://hscrb.harvard.edu/publication/michor-f-chronic-myeloid-leukemia-blast-crisis-arises-from-progenitors-stem-cells-2007-may-2551114-8/ Michor F. Chronic myeloid leukemia blast crisis arises from progenitors. Stem Cells. 2007 May;... https://pure.psu.edu/en/publications/timing-of-allogeneic-hematopoietic-cell-transplantation-allohct-f/ Timing of allogeneic hematopoietic cell transplantation (alloHCT) for chronic myeloid leukemia... timingallogeneichematopoieticcell